Al Janaby, Tina, et al. “Co-Expression of HER2 EGFRvIII CD44 and Claudin 18.2 CD109 As Novel Prognostic Indicators in Stomach Adenocarcinoma”. World Journal of Oncology, Apr. 2025, https://doi.org/10.14740/wjon2552.